_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
Associate Partners:
My Account
Associate Partners:
Associate Partners:
As on 21 Jan, 2021 | 04:00
| Open | 0.00 |
| Previous Close | 0.00 |
| UC Limit | 0.00 |
| LC Limit | 0.00 |
| Volume | 0.00 |
| VWAP | 0.00 |
| Mkt Cap (Rs. Cr.) | 0 |
| 20D Avg Volume | 0 |
| 20D Avg Delivery | -- |
| Beta | 0.000.74 |
| Face Value | 0.00 |
| TTM EPS | -- |
| TTM PE | -- |
| Sector PE | 0.00 |
| Book Value Per Share | -- |
| P/B | -- |
| Dividend Yield | -- |
| P/C | -- |
*Refresh in 20 seconds.
Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation
indicates Average Financials
| Revenue | 7.5% |
| NetProfit | 70.7% |
| OperatingProfit | 12.5% |
| R1 | R2 | R3 | PP | S1 | S2 | S3 | |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Auro Labs Standalone March 2019 Net Sales at Rs 11.53 crore, up 2.23% Y-o-Y May 23 2019 05:05 PM
Auro Labs Standalone December 2018 Net Sales at Rs 12.28 crore, up 0.02% Y-o-Y Jan 29 2019 04:01 PM
Aurobindo buys 7 oncology injectable drugs in $300 million deal Jan 17 2019 08:01 PM
Auro Labs standalone Jun '16 sales at Rs 10.00 crore Aug 16 2016 01:08 PM
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Auro Laboratories Ltd has s...  View more
Posted by : BSE/NSE Announcer
| Qty 100000 | Price 5.8 | % Traded 1.60 |
| Qty 100000 | Price 5.8 | % Traded 1.60 |
| Qty 200000 | Price 5.8 | % Traded 3.21 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 4950 | Price 0 | % Traded 0.08 | Post Tnx Hold. 6.92% |
| Qty 6261 | Price 0 | % Traded 0.10 | Post Tnx Hold. 6.84% |
| Qty 1500 | Price 0 | % Traded 0.02 | Post Tnx Hold. 6.74% |
| Qty 1865 | Price 0 | % Traded 0.03 | Post Tnx Hold. 6.71% |
| Qty 2200 | Price 0 | % Traded 0.04 | Post Tnx Hold. 6.68% |
| Qty 2810 | Price 0 | % Traded 0.05 | Post Tnx Hold. 6.65% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (%) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap | TTM PE | P/B | ROE | 1 Yr Perform | Net Profit | Net Sales | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Auro Labs | 101.30 | -2.17 | 63.14 | 12.28 | 2.94 | 18.86 | 100.79 | 4 | 43 | 0.08 |
| Sun Pharma | 582.90 | -1.98 | 139857.24 | 83.75 | 2.85 | 8.31 | 30.29 | 4,186 | 32,837 | 0.17 |
| Divis Labs | 3604.60 | -0.03 | 95690.80 | 54.43 | 13.08 | 18.76 | 92.68 | 1,372 | 5,310 | 0.00 |
| Dr Reddys Labs | 5052.20 | -0.56 | 84017.13 | 52.21 | 5.39 | 12.98 | 65.08 | 1,969 | 17,517 | 0.11 |
| Cipla | 812.75 | -2.41 | 65544.65 | 35.62 | 4.10 | 9.81 | 71.68 | 1,546 | 17,131 | 0.18 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>
